Generate Biomedicines, Inc. (GENB)
$12.26-11.42%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.6B
- Beta
- -0.14
- P/E (TTM)
- -11.56
- Short % float
- 13.47%
- Days to cover
- 5.8
- SI change
- +3.3%
- 1W
- -11.16%
- 1M
- -23.38%
- vs SPY 1W
- -11.02%
- vs SPY 1M
- -25.88%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on GENB?
- LOPJLB’s latest quantitative signal on Generate Biomedicines, Inc. (GENB) is SELL. Signals are updated daily.
- What market regime is GENB in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Generate Biomedicines, Inc. (GENB) do?
- Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-a…